Verdezyne Inc., a synthetic biology company producing bio-based chemicals, has signed an agreement with Aceto Corporation (ACET), a leader in the marketing, sales and distribution of specialty chemicals in the U.S., for the sales and distribution of Verdezyne’s BIOLON(R) DDDA (bio-based dodecanedioic acid).
“The market is interested in high-quality renewable chemicals such as our BIOLON, which can be used in the production of high-performance nylon 6,12, molding resins, lubricants, adhesives and powder coatings,” said E. William Radany, Ph.D., president and CEO of Verdezyne.
BIOLON(R) DDDA, which is the company’s first product, is produced more sustainably than traditional petroleum-derived intermediate chemicals. BIOLON(R) DDDA has earned the USDA Certified Biobased Product label.
It is also now available worldwide.
“We are excited to bring BIOLON to the U.S. market with Aceto, a highly respected distributor of specialty chemicals. We are certain that through this partnership we will be able to continue to provide excellent customer service and high-quality products to the market,” said Radany.
“Aceto is very excited to add BIOLON to our product offering of polymer building blocks,” said Keith Wilkinson, vice president, specialty chemicals, Aceto. “We are also excited to add a bio-based product to our portfolio that can be offered at competitive prices.”
Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures and Sime Darby.